Fact CheckerSign in

NCT04837846Completed

Multicenter Study Into Individualized Scanning for Coronary Artery Disease

Source: ClinicalTrials.gov · Last updated 12 Nov 2024

Brief summary (registry, in English)

To evaluate intravascular attenuation of the coronary arteries and image quality in an individualized scan and CM injection protocol whereas both scan and injection parameters are tailored to the individual patient in a North American, European and Asian patient population. To evaluate the radiation dose and contrast media dose of this individualized approach for CCTA in an American, European and Chinese patient population. To evaluate the injection parameters required for an average American, European and Chinese patient population.

Status (registry)
Completed
Study type
Observational
Enrollment
60 (actual)
First submitted
6 Apr 2021
Start date
29 Mar 2021
Primary completion date
5 Apr 2024
Lead sponsor
Medical University of South Carolina
NCT number
NCT04837846

What you commit to

  • Study type: Observational
  • Participants enrolled: 60
  • From 29 Mar 2021 to the primary completion date, 5 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • The presence of the following excludes subjects from the study: (All answers must be "NO" for subject to be eligible.)
    • Contraindications for CT coronary angiography, including:
    • Inability to perform a breath hold for at least the expected scan time
    • Unstable angina
    • Hemodynamic instability
    • Known history of CAD
    • Pregnancy
    • Renal insufficiency (defined as Creatinine \<1.5 mg/dL or GFR\<30 mL/min)
    • Iodine allergy
    • Insufficient cannula venous access (preferred 18G, minimal 20G cannula)
    • Subject has an acute psychiatric disorder.
    • Subject is unwilling to comply with the requirements of the protocol.
    • Subject has previously entered this study.

Who the study is looking for

  • To be eligible for the study: (All answers must be "YES" for subject to be eligible.)
    • Referred for a clinically indicated CCTA scan.
    • Patient aged older than 18.
    • Subject must provide written informed consent prior to any study-related procedures being performed.
    • Subject must be willing to comply with all clinical study procedures.
    • Atypical or typical complaints of angina.
    • No previous cardiovascular history.
    • Possibility of 'flash' mode scan; patient heart rate below 70 beats per minute and regular rhythm.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of South Carolina
Coordinator of this site? Confirm its status
CharlestonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.